If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCoca-Cola HBC Regulatory News (CCH)

Share Price Information for Coca-Cola HBC (CCH)

Share Price is delayed by 15 minutes
Get Live Data
5,170.00    30.00 (0.58%)
Bid:
5,160.00
Ask:
5,165.00
Spread: 5.00 (0.097%)
Market Cap: £18.84b
CCH Live PriceLast checked at - London Stock Exchange

Intraday Coca-Cola HBC Share Chart

Result of AGM

21 Jun 2022 16:28

RNS Number : 6898P
Coca-Cola HBC AG
21 June 2022
 

 

 

 
 

FOR IMMEDIATE RELEASE

Coca-Cola HBC AG

Results of Annual General Meeting of Coca-Cola HBC AG

 

 

Zug, Switzerland - 21 June 2022 - Coca-Cola HBC AG ("Coca-Cola HBC") today announces that all of the proposals of the Board of Directors (the "Board") set out in the notice of the annual general meeting ("AGM") dated 19 May 2022 were duly passed by the requisite majority of shareholders at its AGM held today, 21 June 2022. The final results are set out below. A copy of the resolutions passed at the AGM has also been submitted to the National Storage Mechanism and will shortly be available for inspection at  https://data.fca.org.uk/#/nsm/nationalstoragemechanism and on Coca-Cola HBC's website at www.coca-colahellenic.com.

 

The AGM approved a dividend of EUR 0.71 per share ("Dividend") out of the general capital contribution reserve, capped at an amount of CHF 300,000,000. Payment of the full amount of the Dividend will be made on 2 August 2022 to holders of ordinary shares on the record date of 8 July 2022. The shares are expected to be traded ex-dividend as of 7 July 2022, in which case the last day on which the shares may be traded with the entitlement to receive dividends will be 6 July 2022.

 

Resolutions 7 and 9, the advisory votes to approve the UK Remuneration Report and the Swiss Remuneration Report, were passed with approximately 67.17% of the votes cast. Resolution 4.3 in relation to the re-election of Charlotte J. Boyle, Chair of the Remuneration Committee, was also passed with approximately 78.11% of the votes cast. Consequently the Board will initiate a consultation with shareholders on its approach to remuneration which will take place between now and the next AGM in 2023, ensuring as many shareholders as possible are able to provide their feedback on remuneration matters and on an approach to remuneration that aligns as closely as possible with the balance of shareholder views. All other resolutions were passed with high levels of support ranging between approximately 86.54 and 99.94% and shareholders were supportive of Resolution 8 on the Remuneration Policy, which was passed with the support of approximately 96.03% of the votes cast.

 

Final Ballot Results

 

Proposal

Votes

for

%

(1)

Votes Against

%

(1)

Abs-

tentions Cast

%

(1)

Total Votes Cast

Votes not cast (2)

Voting Rights Repre-

sented % (3)

1.

Receipt of the 2021 Integrated Annual Report, as well as approval of the annual management report, the stand-alone financial statements and the consolidated financial statements

269864913

99.92%

86028

0.03%

137729

0.05%

270088670

0

73.71%

2.1.

Appropriation of losses

269925704

99.93%

148603

0.06%

14363

0.01%

270088670

0

73.71%

2.2.

Declaration of dividend from reserves

269890537

99.92%

187270

0.07%

10863

0.01%

270088670

0

73.71%

3.

Discharge of the members of the Board of Directors and the members of the Executive Leadership Team

260526456

96.77%

2939260

1.09%

5760784

2.14%

269226500

0

73.47%

4.1.

Re-election of Anastassis G. David as a member of the Board of Directors and as the Chairman of the Board of Directors

246638953

91.31%

21327040

7.90%

2122677

0.79%

270088670

0

73.71%

4.2.

Re-election of Zoran Bogdanovic as a member of the Board of Directors

265369588

98.25%

4660617

1.73%

58465

0.02%

270088670

0

73.71%

4.3.

Re-election of Charlotte J. Boyle as a member of the Board of Directors and as a member of the Remuneration Committee

210964697

78.11%

59107472

21.88%

16501

0.01%

270088670

0

73.71%

4.4.

Re-election of Reto Francioni as a member of the Board of Directors and as a member of the Remuneration Committee

233729847

86.54%

36065395

13.35%

293428

0.11%

270088670

0

73.71%

4.5.

Re-election of Olusola (Sola) David-Borha as a member of the Board of Directors

265872879

98.43%

4202990

1.56%

12801

0.01%

270088670

0

73.71%

4.6.

Re-election of William W. (Bill) Douglas III as a member of the Board of Directors

265384910

98.26%

4597888

1.70%

105872

0.04%

270088670

0

73.71%

4.7.

Re-election of Anastasios I. Leventis as a member of the Board of Directors

259245411

95.98%

10831867

4.01%

11392

0.01%

270088670

0

73.71%

4.8.

Re-election of Christodoulos (Christo) Leventis as a member of the Board of Directors

259650806

96.13%

10427168

3.86%

10696

0.01%

270088670

0

73.71%

4.9.

Re-election of Alexandra Papalexopoulou as a member of the Board of Directors

234814094

86.93%

35262820

13.06%

11756

0.01%

270088670

0

73.71%

4.10.

Re-election of Ryan Rudolph as a member of the Board of Directors

257233915

95.24%

12842650

4.75%

12105

0.01%

270088670

0

73.71%

4.11.

Re-election of Anna Diamantopoulou as a member of the Board of Directors and as a member of the Remuneration Committee

253007955

93.67%

17067263

6.32%

13452

0.01%

270088670

0

73.71%

4.12.

Re-election of Bruno Pietracci as a member of the Board of Directors

257328585

95.27%

12092001

4.48%

668084

0.25%

270088670

0

73.71%

4.13.

Re-election of Henrique Braun as a member of the Board of Directors

257328864

95.28%

12044465

4.46%

715341

0.26%

270088670

0

73.71%

5.

Election of the independent proxy

269972863

99.95%

102789

0.04%

13018

0.01%

270088670

0

73.71%

6.1.

Re-election of the statutory auditor

266026652

98.49%

4051262

1.50%

10756

0.01%

270088670

0

73.71%

6.2.

Advisory vote on re-appointment of the independent registered public accounting firm for UK purposes

265942622

98.46%

4133626

1.53%

12422

0.01%

270088670

0

73.71%

7.

Advisory vote on the UK Remuneration Report

181440565

67.17%

88630436

32.82%

17669

0.01%

270088670

0

73.71%

8.

Advisory vote on the Remuneration Policy

259376317

96.03%

10695685

3.96%

16668

0.01%

270088670

0

73.71%

9.

Advisory vote on the Swiss Remuneration Report

181440565

67.17%

88630436

32.82%

17669

0.01%

270088670

0

73.71%

10.1.

Approval of the maximum aggregate amount of remuneration for the Board of Directors until the next annual general meeting

269821962

99.92%

204088

0.08%

62620

n.a.

270026050

0

73.71%

10.2.

Approval of the maximum aggregate amount of remuneration for the Executive Leadership Team for the next financial year

267013278

98.89%

2998680

1.11%

76712

n.a.

270011958

0

73.71%

11.

Approval of share buy-back

269233757

99.69%

174320

0.06%

680593

0.25%

270088670

0

73.71%

12.

Approval of the amendments to the articles 11, 16, 27, 30, 32, 33, 34, 35, 36, 37 and 38 of the Articles of Association regarding the replacement of the term "Operating Committee" by the term "Executive Leadership Team"

269906090

99.94%

120093

0.04%

62487

0.02%

270088670

0

(0.00)

73.71%

 

(1) Percentages refer to applicable majority. Proposals 1-9 and 11 require approval by an absolute majority of the votes validly cast (including consenting and dissenting votes and abstentions). Proposals 10.1 and 10.2 require approval by a relative majority of the votes validly cast (including consenting and dissenting votes without abstentions). Proposal 12 requires approval by a majority of at least two-thirds of the voting rights represented and an absolute majority of the nominal value of shares represented.

 

(2) Votes represented at the AGM but not (or not validly) cast.

 

(3) Shares represented at the AGM for each proposal as a percentage of Coca-Cola HBC's outstanding voting rights, whether exercisable or not. As at the date of the AGM, Coca-Cola HBC's issued share capital consisted of 371,809,001 ordinary shares, of which 1,956,582 ordinary shares are held by Coca-Cola HBC AG and 3,430,135 shares are held by its subsidiary, COCA-COLA HBC SERVICES MEPE, in treasury. Accordingly, the total number of outstanding voting rights (whether exercisable or not) in Coca-Cola HBC AG was 366,422,284.

 

Following the re-election of all the directors as set out above, the composition of each of the Board Committees remains unchanged.

 

Enquiries

Coca‑Cola HBC Group

 

Investors and Analysts:

Joanna Kennedy

Investor Relations Director

Tel: +44 7802 427505

 joanna.kennedy@cchellenic.com

Jemima Benstead

Investor Relations Manager

Tel: +44 7740 535130

jemima.benstead@cchellenic.com

Marios Matar

Investor Relations Manager

Tel: +30 697 444 3335

marios.matar@cchellenic.com

Media:

David Hart

Group Communication Director

Tel: +41 41 726 0143

 david.hart@cchellenic.com

 

 

 

About Coca‑Cola HBC

Coca-Cola HBC is a growth-focused consumer packaged goods business and strategic bottling partner of The Coca-Cola Company. We create value for all our stakeholders by supporting the socio-economic development of the communities in which we operate and we believe building a more positive environmental impact is integral to our future growth. Together, we and our customers serve 715 million consumers across a broad geographic footprint of 29 countries on three continents. Our portfolio is one of the strongest, broadest and most flexible in the beverage industry, offering consumer-leading beverage brands in the sparkling, juice, water, sport, energy, plant-based, ready-to-drink tea, coffee, adult sparkling and premium spirits categories. These beverages include Coca-Cola, Coca-Cola Zero, Schweppes, Kinley, Costa, Valser, Romerquelle, Fanta, Sprite, Powerade, FuzeTea, Dobry, Cappy, Monster and Adez. We foster an open and inclusive work environment amongst our 36,000 employees and we are ranked among the top sustainability performers in ESG benchmarks such as the Dow Jones Sustainability Indices, CDP, MSCI ESG and FTSE4Good.

Coca-Cola HBC has a premium listing on the London Stock Exchange (LSE:CCH) and is listed on the Athens Exchange (ATHEX:EEE). For more information, please visit https://www.coca-colahellenic.com/

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RAGEASKFAADAEFA
Date   Source Headline
23rd Dec 20252:45 pmRNSDirector/PDMR Shareholding
23rd Dec 20252:45 pmRNSDirector/PDMR Shareholding
22nd Dec 20252:15 pmRNSDirector/PDMR Shareholding
22nd Dec 20252:15 pmRNSDirector/PDMR Shareholding
18th Dec 20255:00 pmRNSDirector/PDMR Shareholding
18th Dec 20255:00 pmRNSDirector/PDMR Shareholding
18th Dec 20253:15 pmRNSDirector/PDMR Shareholding
18th Dec 20253:15 pmRNSDirector/PDMR Shareholding
17th Dec 20257:00 amRNSNotice of EGM
24th Nov 20252:15 pmRNSDirector/PDMR Shareholding
18th Nov 20254:10 pmRNSDirector/PDMR Shareholding
5th Nov 20251:45 pmRNSDirector/PDMR Shareholding
3rd Nov 20259:30 amRNSBlock listing Interim Review
30th Oct 20253:00 pmRNSHolding(s) in Company
23rd Oct 20252:10 pmRNSDirector/PDMR Shareholding
23rd Oct 20252:00 pmRNSDirector/PDMR Shareholding
21st Oct 20257:03 amRNSSolid Q3 performance; guidance reiterated
21st Oct 20257:00 amRNSCCH to acquire Coca-Cola Beverages Africa
20th Oct 20253:45 pmRNSDirector/PDMR Shareholding
30th Sep 202511:30 amRNSNotice of Results
18th Sep 20252:30 pmRNSDirector/PDMR Shareholding
19th Aug 202512:00 pmRNSDirector/PDMR Shareholding
6th Aug 20257:00 amRNSConsistent execution delivers strong H1 results
4th Aug 20254:45 pmRNSRevolving Credit Facility
18th Jul 202512:15 pmRNSDirector/PDMR Shareholding
15th Jul 20251:00 pmRNSBitesize Investor Series – Nigeria
7th Jul 20251:09 pmRNSNotice of Results
3rd Jul 202510:04 amRNSHolding(s) in Company
2nd Jul 20253:29 pmRNSHolding(s) in Company
30th Jun 20253:32 pmRNSDirector/PDMR Shareholding
30th Jun 20251:44 pmRNSHolding(s) in Company
18th Jun 20252:55 pmRNSDirector/PDMR Shareholding
3rd Jun 20251:19 pmRNSDirector/PDMR Shareholding
2nd Jun 20258:07 amRNSTransfer of treasury shares & total voting rights
23rd May 20252:05 pmRNSComposition of the Board Committees
23rd May 20251:55 pmRNSResult of AGM and dividend dates
20th May 20252:37 pmRNSDirector/PDMR Shareholding
19th May 202512:22 pmRNSDirector/PDMR Shareholding
7th May 20252:33 pmRNSDirector/PDMR Shareholding
1st May 20259:37 amRNSBlock listing Interim Review
1st May 20259:23 amRNSTransfer of treasury shares & total voting rights
30th Apr 20257:00 amRNSStrong start; reiterating 2025 guidance
23rd Apr 20251:38 pmRNSAGM Notice,changes to BoD,dividend dates-Amendment
23rd Apr 20257:00 amRNSNotice of AGM, changes to the BoD, dividend dates
22nd Apr 202512:42 pmRNSDirector/PDMR Shareholding
2nd Apr 202510:13 amRNSNotice of Results
1st Apr 20259:23 amRNSTransfer of treasury shares & total voting rights
28th Mar 20252:43 pmRNSDirector/PDMR Shareholding
28th Mar 20252:42 pmRNSDirector/PDMR Shareholding
28th Mar 20252:37 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.